Literature DB >> 12000821

Pheochromocytoma--death of an axiom.

Robert G Dluhy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12000821     DOI： 10.1056/NEJM200205093461911

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  Percutaneous ablation of adrenal tumors.

Authors:  Aradhana M Venkatesan; Julia Locklin; Damian E Dupuy; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2010-06

Review 2.  Screening for genetic causes of hypertension.

Authors:  Robert G Dluhy
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

Review 3.  Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.

Authors:  Judith Favier; Laurence Amar; Anne-Paule Gimenez-Roqueplo
Journal:  Nat Rev Endocrinol       Date:  2014-11-11       Impact factor: 43.330

4.  Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.

Authors:  Monica L Marvin; Carol R Bradford; James C Sisson; Stephen B Gruber
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

Review 5.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

6.  Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?

Authors:  Paraskevi Xekouki; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

7.  Clinical experience with pheochromocytoma in a single centre over 16 years.

Authors:  Dario Cotesta; Luigi Petramala; Valentina Serra; Mario Pergolini; Eleonora Crescenzi; Laura Zinnamosca; Giorgio De Toma; Antonio Ciardi; Iacopo Carbone; Rita Massa; Sebastiano Filetti; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

8.  Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Authors:  Birke Bausch; Francesca Schiavi; Ying Ni; Jenny Welander; Attila Patocs; Joanne Ngeow; Ulrich Wellner; Angelica Malinoc; Elisa Taschin; Giovanni Barbon; Virginia Lanza; Peter Söderkvist; Adam Stenman; Catharina Larsson; Fredrika Svahn; Jin-Lian Chen; Jessica Marquard; Merav Fraenkel; Martin A Walter; Mariola Peczkowska; Aleksander Prejbisz; Barbara Jarzab; Kornelia Hasse-Lazar; Stephan Petersenn; Lars C Moeller; Almuth Meyer; Nicole Reisch; Arnold Trupka; Christoph Brase; Matthias Galiano; Simon F Preuss; Pingling Kwok; Nikoletta Lendvai; Gani Berisha; Özer Makay; Carsten C Boedeker; Georges Weryha; Karoly Racz; Andrzej Januszewicz; Martin K Walz; Oliver Gimm; Giuseppe Opocher; Charis Eng; Hartmut P H Neumann
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

9.  Pheochromocytoma in Urologic Practice.

Authors:  Nikhil Waingankar; Gennady Bratslavsky; Camilo Jimenez; Paul Russo; Alexander Kutikov
Journal:  Eur Urol Focus       Date:  2016-09-28

10.  One genotype, many phenotypes: SDHB p.R90X mutation-associated paragangliomas.

Authors:  Ali S Alzahrani; Meshael Alswailem; Yosra Moria; Ayman Aldeheshi; Hindi Al-Hindi
Journal:  Endocrine       Date:  2020-08-17       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.